According to Novartis Animal Health, Sentinel is back on the market at a new, low price. Sentinel provides year-round intestinal parasite, heartworm, and flea protection for dogs.
Because of the broader spectrum and competitively priced protection Sentinel now offers, Novartis has announced the discontinuation of Interceptor production for the U.S. market.
Sentinel requires a written prescription from a licensed veterinarian, so consumers should consult with their pet’s veterinarian regarding any change from an existing treatment to Sentinel.
Novartis first announced the suspension in production of several of its products in early 2012, see here.